PREDICT-HPNCT04844359
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 10 words
- Primary endpoints: details revised at 17 of 40 entries
- Trial completed
- Notable Primary completion date: Jul 30, 2025 to Jul 30, 2026
- Study completion date: Jul 31, 2025 to Jul 31, 2026
Notable Primary completion date: Jan 2025 to Jul 30, 2025v8 Show 4 more changesShow less
- Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 135 to confirmed 137
- Study completion date: Jan 2026 to Jul 31, 2025
- Site details revised at 7 of 7 sites
- Minor Study sites: 6 to 7
- Collaborators: 5 to 6
- Notable Eligibility criteria shortened, about 5 words
- Study sites: 5 to 6
- Collaborators: 4 to 5
Show 3 earlier versionsHide 3 earlier versions
- Notable Primary completion date: Jan 2024 to Jan 2025
- Eligibility criteria shortened, about 2 words
- Study completion date: Jan 2025 to Jan 2026
- Site details revised at 3 of 5 sites
- Notable Primary completion date: Jan 2023 to Jan 2024v3
- Notable Primary endpoints revised (40)v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Time to absolute FVC (percent predicted) decline ≥10 percent
Timeframe: Up to 24 months
Time to absolute DLCO (percent predicted) decline ≥10 percent
Timeframe: Up to 24 months
Time to relative FVC (percent predicted) decline ≥10 percent
Timeframe: Up to 24 months
Time to relative DLCO (percent predicted) decline ≥10 percent
Timeframe: Up to 24 months
Time to relative DLCO (percent predicted) decline ≥15 percent
Timeframe: Up to 24 months
Time to first adjudicated acute chronic hypersensitivity pneumonitis exacerbation
Timeframe: Up to 24 months
Need for a new course of oral or intravenous steroids
Timeframe: Up to 24 months
Time to death from any cause
Timeframe: Up to 24 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 6
Timeframe: 6 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 12
Timeframe: 12 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 18
Timeframe: 18 months
Change from baseline in St. George's Respiratory Questionnaire total score at month 24
Timeframe: 24 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 6
Timeframe: 6 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 12
Timeframe: 12 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 18
Timeframe: 18 months
Change from baseline in dyspnea using University of California San Diego Shortness of Breath Questionnaire at month 24
Timeframe: 24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 6
Timeframe: 6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 12
Timeframe: 12 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 18
Timeframe: 18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire symptoms score at month 24
Timeframe: 24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 6
Timeframe: 6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 12
Timeframe: 12 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 18
Timeframe: 18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire activity score at month 24
Timeframe: 24 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 6
Timeframe: 6 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 12
Timeframe: 12 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 18
Timeframe: 18 months
Change from baseline in dyspnea using St. George's Respiratory Questionnaire impact score at month 24
Timeframe: 24 months
Change from baseline in CT visual (≥10 percent) score at month 12
Timeframe: 12 months
Change from baseline in CT visual (≥10 percent) score at month 24
Timeframe: 24 months
Change from baseline in CT quantitative (≥3.4) score at month 12
Timeframe: 12 months
Change from baseline in CT quantitative (≥3.4) score at month 24
Timeframe: 24 months
Change from baseline in 6-min walk distance at month 6
Timeframe: 6 months
Change from baseline in 6-min walk distance at month 12
Timeframe: 12 months
Change from baseline in 6-min walk distance at month 18
Timeframe: 18 months
Change from baseline in 6-min walk distance at month 24
Timeframe: 24 months
Rate of decline in FVC (percent predicted) over 24 months
Timeframe: Up to 24 months
Rate of decline in FVC (ml) over 24 months
Timeframe: Up to 24 months
Rate of decline in DLCO (percent predicted) over 24 months
Timeframe: Up to 24 months
Rate of decline in DLCO (mmol/min/kpa) over 24 months
Timeframe: Up to 24 months
Sites
7 sites in 1 country